Background
Depression is a common psychiatric problem associated with autism spectrum disorder (ASD) across the lifespan.
Objective
We sought to identify medical and behavioral problems associated with a history of a parent reported diagnosis of depression in a large sample of school-aged children and adolescents with ASD.
Methods
A sample of 1272 participants (age 6–17 years, M=9.56, SD=2.79) from the Autism Speaks-Autism Treatment Network (AS-ATN) consortium was divided into “Ever-Depressed” (n=89) and “Non-Depressed” (n=1183) groups based on caregiver endorsement of children’s current or previous diagnoses of depression.
Results
7.0% of children with ASD (4.8% of those aged 6–12 and 20.2% of those aged 13–17) were reported to have a history of a depression diagnosis. Positive depression history was associated with greater chronological age, higher IQ, and Asperger’s Disorder diagnosis. After controlling for age, IQ, and DSM-IV ASD diagnostic subtype, the Ever-Depressed group exhibited significantly greater rates of seizure disorders (OR= 2.64) and gastrointestinal problems (OR=2.59), and trend level differences in aggression, somatic complaints, and social impairments. The groups did not differ in autism severity, repetitive and compulsive behaviors, sleep problems, eating problems, self-injurious behavior, or use of behavior, social, or educational interventions or therapies.
Conclusions
Co-occurring depression is a particularly common problem in higher-functioning, older children within the AS-ATN. Our findings indicate that children with ASD who have a parent reported history of a depression diagnosis are more likely to also have co-occurring medical problems, although the presence and direction of causality is unclear.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.